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Abstract The 5P-upstream region (1.3 kb) of the gene encoding
the POU domain transcription factor Oct-1 was cloned and
sequenced. CAT reporter gene analysis of this region has
detected a functionally active promoter. This region contains
24 TAAT-core sites, arranged in five clusters (four to six sites in
one cluster) ; two octamer sites (ATGCAAAT) are located in the
first and second clusters; in the second one the CCAAT-box
adjacent to the octamer overlaps with the TAAT-core site. As
shown by gel retardation assay, Oct-1, Oct-2, and some unknown
proteins from myeloma cell line NS/0 interact with the TAAT-
core sites of these clusters. The results suggest autoregulation of
Oct-1 gene expression that may also be controlled by other POU
proteins, homeodomain proteins and CCAAT trans-action
factors.
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1. Introduction
Oct proteins belong to the POU domain transcription fac-
tor family. The Oct-1 protein is a universal transcription fac-
tor expressed in all dividing cells [1,2]. It is involved in regu-
lation of gene expression, and is therefore essential for
proliferation, di¡erentiation and other key cell processes. Tar-
get genes controlled by Oct-1 include those encoding snRNAs
[3], histone H2B [4], interleukin (IL) 3, IL-5, granulocyte/mac-
rophage colony stimulating factor [5], IL-8 [6], gonadotropin-
releasing hormone (GnRH) [7], human thyrotropin-L (hTSHL)
[8], thyroid transcription factor 1 (TTF-1) [9], Pit-1 [10], and
also the K/immediate early genes of herpes simplex virus [11].
There are two Oct-1 forms in the nucleus, soluble and insolu-
ble; the latter forms a complex with the nuclear matrix [8].
Oct-1 binding to DNA may either stimulate or inhibit tran-
scription. The octamer sequence ATGCAAAT is involved in
high-a⁄nity Oct-1 binding. Some regulatory elements have a
modi¢ed sequence also recognized by Oct-1, for example AT-
GATAATGAG and TAATGARAT elements [12^14]. In vi-
tro experiments have shown Oct-1 and Oct-2 proteins binding
with many octamer-related binding sites and with TAAT-
core-containing homeospeci¢c sequences [15^19].
POU proteins share a highly conservative DNA binding
domain (POU domain) which may be subdivided into two
subdomains termed POU speci¢c (POUs) and POU homeo
(POUh) domain [1]. As shown by our and others’ studies of
Oct protein interactions with TAAT-core sites in vitro, only
POUh domain binds to these sites [16^19]. However, the en-
tire POU domain is involved in the interaction with the can-
onical oct site ATGCAAAT. Therefore, the a⁄nity of Oct
proteins towards the TAAT-core sites is lower than their af-
¢nity towards the canonical oct sites. Interaction of Oct-2
protein with TAAT-core sites depends strongly on the two
3P-£anking nucleotides in 5P-TAATNN-3P [17,19]. This is
true also for homeoproteins [20].
Interaction of Oct protein with other transcription factors
and coregulators provides ¢ne regulation of gene expression
[21^23]. The DNA binding Oct-1 protein activity in vivo is
controlled by a cell cycle-dependent kinase: phosphorylation
of Ser385 in Oct-1 during mitosis prevents Oct-1 binding to an
octamer element [24].
The human OTF-1 gene is encoded by 16 exons spanning
over 150 kb [25]. Human Oct-1 cDNA was cloned and se-
quenced [4], its high homology with murine Oct-1 cDNA
was shown [4].
The aim of this work was to analyze the structure and
functioning of the untranscribed 5P-region of the Oct-1 gene.
This appeared important taking into account that cis- and
trans-factors regulating Oct-1 expression are not yet known.
The results allowed us to suggest autoregulation of Oct-1 gene
expression.
2. Materials and methods
2.1. Genomic library: construction and screening
Enriched genomic library was constructed using a 1.5^3.0 kb frac-
tion of PTF-02 cell DNA digested with EcoRI. Total DNA (about 80
Wg) from the murine myeloma cell line PTF-02 was digested with
EcoRI. The fragment of interest was detected by Southern blot hy-
bridization (20 Wg DNA-EcoRI) with a 176 bp Oct-1 cDNA fragment.
The DNA probe for Southern blotting was prepared from Oct-1
cDNA isolated earlier [26]. Untranslated 176 bp cDNA fragment
was obtained by EcoRI-XbaI digestion and 32P-labelled by nick-trans-
lation. Only one 2.2 kb band was identi¢ed. This band was isolated
from the remaining DNA (60 Wg) after electrophoresis under the same
conditions using phenol/chloroform extraction and then ligated with
the EcoRI arms of Vgt10 vector (Promega). The library was screened
using Lambda gt10 vector kit (Promega) according to the manufac-
turer’s instruction with the same DNA probe as for Southern blotting.
Subcloning and sequencing were carried out in plasmid pUC18.
DNA was sequenced using T7 DNA polymerase (Fermentas) and
universal primers.
2.2. Oligonucleotides
Double-stranded oligonucleotides containing the oct sequence or
TAAT-core sequence were used as probes for electromobility shift
assay. Flanking sequences of these probes were identical and con-
tained no additional TAAT or ATGC motifs (Table 1).
2.3. Electromobility shift assay
Myeloma cell lysate (line NS/0) was prepared as described earlier
[27]. Electromobility shift assay was performed as described [28] with
0.3 ng of 32P-labelled oligonucleotide, 0.5 Wg of poly(dGdC)po-
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ly(dGdC) and some experiments with 15 ng of ‘cold’ oct probe. Ex-
perimental conditions were the same for all TAAT-core probes.
2.4. Cell transfection and CAT reporter gene analysis
The 1.3 kb PstI-EcoRI 5P-upstream fragment with part of the ¢rst
exon of the Oct-1 gene (Fig. 1) was cloned on pCAT Enhancer Vector
(Promega) (pCAT.Oct-1). Transfection was performed using transfec-
tam reagent (Promega) in NB41A3 and HepII cells with recombinant
pCAT.Oct-1 vector and pCAT Control vector (Promega) in six cell
dishes at about 60% cell density (1 Wg DNA; transfectam reagent:D-
NA=4:1). CAT analysis was run with Promega kit as recommended
by the manufacturer.
3. Results
3.1. Murine Oct-1 5P-upstream region contains multiple
TAAT-core sites and oct sites
By screening the enriched genomic library we found a clone
with a 2.2 kb insert. As shown by restriction analysis and
sequencing, this insert contained the 1.3 kb 5P-upstream re-
gion, a 27 base ¢rst exon of the Oct-1 gene, and a 0.87 kb
region of the ¢rst intron. Two canonical oct sequences ATG-
CAAAT of opposite orientation were found in the 5P-region,
3412 bp, 3535 bp upstream from the translation start site
(Fig. 1A). Three oct-related sequences were also found in this
region: two with single substitutions, TTGCAAAT at 399 bp
and ATCCAAAT at 3822 bp and one with a nucleotide in-
sert between the POUs and POUh recognition sites, ATGC-
cAAAT at 31168 bp. The region from 3293 to 31261 bp
contained ¢ve AT-rich clusters separated by 80^170 bp
spacers. The A/T to G/C ratio in these clusters exceeds the
same ratio in spacers about two times. Twenty-four homeo-
speci¢c-like sites with TAAT-core sequence are located in
these clusters (Fig. 1). The ¢rst cluster contained four
TAAT-core sites and an oct sequence. The second cluster
had six TAAT-core sites, an octamer of reversed orientation,
and also two CCAAT sites of opposite orientation. The latter
may be a target for CCAAT binding proteins. This cluster
had two overlaps of the cis-elements: four crossed sequences
(oct, CCAAT and two TAAT) and three overlapping TAAT-
core sites. The third cluster had ¢ve TAAT-core sites and two
oct-related sequences. The fourth cluster had three TAAT-
core sites. One more TAAT site was found between the third
and fourth clusters. The ¢fth cluster had ¢ve TAAT-core sites
and an oct-related sequence.
3.2. The 5P-upstream region (EcoRI-PstI) of the Oct-1 gene
has promoter activity
CAT reporter gene analysis of the 5P-upstream region re-
vealed a functionally active promoter. Promoter activity of the
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Fig. 1. Murine Oct-1 promoter. A: Nucleotide sequences of AT-rich clusters containing TAAT-core sequences; oct sites, oct-related sites,
TAAT-core sites and CCAAT sites are underlined. The amino acid sequence of the ¢rst exon is indicated. Untranslated region of cDNA and
¢rst exon are underlined. B: Schematic cluster organization showing the TAAT-core sites (M), oct (8), oct-related sites (P) and CCAAT sites
(6) ; overlapping sites are underlined.
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Oct-1 5P-upstream region was about 20 times lower than that
of the pCAT control vector containing SV40 virus promoter
(Fig. 2).
3.3. The TAAT-core sites from the 5P-upstream region of the
Oct-1 gene bind Oct proteins and some other nuclear
proteins
Electromobility shift assay has shown varying a⁄nity of
Oct-1 and Oct-2 proteins from the NS/0 myeloma cell extract
towards the TAAT-core sites depending on the two 3P-£ank-
ing nucleotides of the probe 5P-TAATNN-3P (Fig. 3A,B).
Some unidenti¢ed proteins also interacted with the TAAT-
core probes (Fig. 3A,B). High a⁄nity to Oct proteins was
shown for the TAATTT, TAATGA, and TAATTA sites, con-
¢rming the data on the high a⁄nity of the Oct-2 POU domain
to these sites obtained earlier (Table 2) [19]. The interaction
with TAATTT and TAATGA was completely inhibited by
the ‘cold’ oct probe. Other TAAT-core sites from the 5P-up-
stream region (TAATCA, TAATTG, TAATTA, TAATAT,
TAATCT, TAATGG) interacted with Oct proteins showing
di¡erent a⁄nity and they also bound unidenti¢ed nuclear
proteins (interaction was not a¡ected or was not completely
inhibited by the ‘cold’ oct probe).
4. Discussion
The data available on the structure of the promoter and
enhancer regions in Oct-1-regulated genes suggest that the
sites involved in regulation of gene expression by Oct-1 in
vivo form three groups (Table 3): (1) the canonical oct site
ATGCAAAT; (2) non-canonical oct sites with single nucleo-
tide substitutions (oct-related sites) and (3) TAAT-core sites.
The canonical oct site ATGCAAAT binds the Oct-1 protein
with the highest a⁄nity. This sequence is found in promoter
and enhancer regions of the actively transcribed Oct-1-acti-
vated genes, for example in the genes encoding H2B histone
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Fig. 2. CAT analysis of the Oct-1 gene 5P-upstream region. A: Sche-
matic map of the pCAT.Oct-1 construct and pCAT control vector.
B: Comparison of Oct-1 promoter activity and SV40 promoter ac-
tivity. Cells were harvested 48 h after transfection and equal
amounts assayed for CAT activity.
Fig. 3. Electromobility shift assay analysis of the TAAT-core elements in the murine Oct-1 promoter. Lanes 1, 0.3 Wg 32P-labelled probe; lanes
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[4] and U1, U2, U6, 7SK snRNAs [3,28^32]. The oct site is
also present in the human Pit-1 gene promoter, however tran-
scriptional activity of this gene is negatively regulated by Oct-
1 protein [10].
The promoter and enhancer regions of many genes con-
trolled by Oct-1 protein contain Oct-1-speci¢c sites of lower
a⁄nity: oct-related sites and TAAT-core sites (Table 3). The
TAAT-core sites in the regulatory gene regions appear impor-
tant for Oct-1 protein functioning. TAAT-core sites may be
involved in either gene repression or activation, or may be
essential for replication and chromatin loop formation.
The Oct-1 protein activates transcription of TTF-1. The
promoter of the TTF-1 gene has two functionally active
TAAT-core sites, TAATTA and TAATTG, interacting with
the Oct-1 protein [9]. The prolactin gene promoter has two
sites binding Oct-1 and Pit-1 proteins [33]. These transcription
factors appear to interact simultaneously with this region with
a synergistic e¡ect on prolactin gene transcription. The Oct-1
binding site contains a TAATCA sequence.
As shown for some genes, Oct-1 may also act as a repress-
or. Oct-1 strongly represses transcriptional activity of the IL-8
promoter by binding to the non-canonical oct site
TTGCAAAT [6]. Oct-1 is possibly involved in hormone-de-
pendent transcriptional repression of GnRH. Oct-1 in com-
plex with a glucocorticoid receptor interacts with the distal
promoter of the GnRH gene. The Oct-1 binding site contains
a TAATGA sequence [7]. At least in some cases, the repres-
sive function of the Oct-1 protein may be related to chromatin
loop formation. It was shown that Oct-1 is involved in nuclear
matrix formation. An AT-rich fragment with numerous over-
lapping TAATAA and TAATAT sites was found in the pro-
moter of the hTSHL gene. Binding of Oct-1 protein by this
region is important for silencing of the hTSHL promoter. A
signi¢cant fraction of Oct-1 was shown to be associated with
the nuclear matrix, suggesting a possible role of the Oct-1-
hTSHL silencer interaction in chromatin organization [8].
Oct-1 acts also as a replication factor, at least for viral
genomes. In human adenoviruses the origin of replication
contains sequences interacting with Oct-1. The canonical oct
sequence as well as oct-related sequences and TAAT-core se-
quences were found in the origin of replication of human
adenoviruses. The e¡ect of Oct-1 depends on its a⁄nity to-
wards the binding site ; an origin containing a high a⁄nity oct
site is stimulated to a higher level than a low a⁄nity site
[34,35].
Oct-1 plays multiple roles in the cell, acting as a positive or
negative regulator of gene transcription, DNA replication,
and possibly anchoring chromatin loops to the nuclear matrix.
The pleiotropic e¡ect of Oct-1 in cells is based on the follow-
ing. First, Oct-1 protein interacts with DNA as a monomer or
forms heterodimers with tissue-speci¢c transcription factors,
or forms complexes with coactivators depending on the bind-
ing site. For example, the VP16 protein interacts with Oct-1
only when it binds to the TAATGARAT site [11] and a com-
plex with Oca-B (OBF-1/Bob1) is formed only if Oct-1 or Oct-
2 bind to the canonical oct site ATGCAAAT [21^23]. Second,
in vivo Oct-1 acts via the DNA sites of three types, interacting
with them with di¡erent a⁄nity.
Regulation of the Oct-1 gene expression probably depends
on all three types of the Oct-1 binding elements (Tables 2 and
3). As shown in this work, the 5P-region of the Oct-1 gene
contains two canonical oct sites, three oct-related sites, and 24
TAAT-core sites, arranged in ¢ve clusters (Fig. 1). These sites
vary in their a⁄nity towards Oct-1 binding. Moreover, the
TAAT-core sites may bind some other proteins, so the inter-
action of the TAAT-core site with nuclear protein depends on
the concentration of proteins in a cell. TAAT-core sites, even
if transcriptionally inactive, may bind the Oct proteins in-
creasing the local concentration of the Oct proteins at this
region of the chromosome.
The CCAAT sites may also be important in Oct-1 gene
regulation. It was shown [6] that the CCAAT enhancer bind-
ing protein (C/EBP) and Oct-1 act as antagonists for regula-
tion of IL-8 gene transcription; Oct-1 strongly represses the
transcriptional activity of the IL-8 promoter by binding inde-
pendently to an element overlapping with the C/EBP binding
site [6]. The second cluster of the 5P-upstream region of the
Oct-1 gene contains two CCAAT sequences of opposite ori-
entation (Fig. 1A). One of them, four bases upstream of the
oct sequence, overlaps with the TAATTG site, which interacts
in NS/0 cells with an unknown protein, probably a homeo-
protein (Fig. 3A). This region contains four overlapping sites:
an oct site, two TAAT sites, and a CCAAT site (Fig. 1A).
This suggests a tight interaction of the Oct, homeo, and
CCAAT binding proteins for regulation of Oct-1 gene expres-
sion. The cooperativity and complex pattern of this interac-
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Table 2
Number of copies of the TAAT-core sites in the Oct-1 gene 5P-up-
stream region and relative Kd values [19] for the Oct-2 POU do-
main











ATGCAAAT 2 1 max a⁄nity
nd, not determined.
Table 3















GnRH(3216 to 3201) AAGATTTTAATGACCT
hTSHL TTAATATAATAAATAA
TTTATTAATATTAAT
IL-3 (3157 to 3145) GGATGAATAATTA
IL-5 (346 to 359) AAATGAATAATTT
GM-CSF (338 to 350) AAATGATTAATGG
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tion are con¢rmed by clustering of the sites. Also we suggest
Oct-1 gene autoregulation via oct sites and TAAT-core sites.
Autoregulation is involved in the control of other genes of the
POU family: murine and human genes encoding Pit-1 [10,35],
and the human Brn-4 gene [36].
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